Miriam Kidron Net Worth & Insider Trades
Miriam Kidron - Chief Scientific Officer, Oramed Pharmaceuticals Inc
What is Miriam Kidron's Net Worth?
The current estimated net worth of Oramed Pharmaceuticals Inc's Chief Scientific Officer, Miriam Kidron, is estimated to be about $4.66M . Miriam Kidron owns about 75,000 units of Oramed Pharmaceuticals Inc common stock. In the last 15 years at Oramed Pharmaceuticals Inc, Miriam Kidron has sold an estimated value of $3.54M worth.
What is Miriam Kidron's Past Insider Trading?
Miriam Kidron's largest purchase order was 137,300 units , worth over $1.65K on April 3, 2014. Miriam Kidron's largest sale order was 137,300 units , worth over $1.65M on April 3, 2014. In total, Miriam Kidron has made about 22 transactions over 15 years of their time at Oramed Pharmaceuticals Inc. Miriam Kidron usually trades in August, February and September, with the busiest year in 2014. The most recent transaction was a sale order of 89,636 units , worth over $761.91K on August 3, 2017.
Miriam Kidron
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
What was Miriam Kidron's Salary in 2020?
As Chief Scientific Officer of Oramed Pharmaceuticals Inc, Miriam Kidron has a total base salary of $305,840 . Miriam Kidron received compensation valued at about $688,700 in 2020 after becoming Chief Scientific Officer. The vast majority of their compensation came in the form of a bonus of $70,000 , option awards of $299,506 , and other compensation of $13,354 .
What is Miriam Kidron's' Mailing Address?
- Mailing address is 2 Elza Street Jerusalem L3 93706 Israel
Oramed Pharmaceuticals Inc Executive Compensation
Name |
Year
|
Salary
|
Bonus
|
Option Awards
|
Other Compensation
|
Total
|
|---|---|---|---|---|---|---|
| Nadav Kidron | 2020 | $439,076 | $220,582 | $569,062 | $539,131 | $1,767,851 |
| Nadav Kidron | 2019 | $419,460 | $224,975 | $398,910 | $507,750 | $1,551,095 |
| Nadav Kidron | 2018 | $436,310 | $148,795 | $522,569 | $442,326 | $1,550,000 |
| Miriam Kidron | 2020 | $305,840 | $70,000 | $299,506 | $13,354 | $688,700 |
| Miriam Kidron | 2019 | $267,386 | $123,149 | $211,128 | $14,503 | $616,166 |
| Miriam Kidron | 2018 | $273,595 | $46,614 | $253,204 | $13,643 | $587,056 |
| Avraham Gabay | 2020 | $130,554 | $15,591 | - | $44,912 | $191,418 |
| Avraham Gabay | 2019 | $32,122 | - | $73,928 | $9,441 | $115,491 |
| Joshua Hexter | 2020 | $190,801 | $12,169 | $351,128 | $54,735 | $608,833 |
| Joshua Hexter | 2019 | $52,848 | - | - | $9,022 | $61,870 |
| Joshua Hexter | 2018 | $161,002 | $26,895 | $269,196 | $50,505 | $507,598 |
| No matching records found | ||||||
Source: https://www.sec.gov/Archives/edgar/data/1176309/000121390021039099/ea144766-def14a_oramedpharma.htm
What are Oramed Pharmaceuticals Inc's Past Insider Trades?
Oramed Pharmaceuticals Inc's most recent insider trade came on May 10, 2022 by Arie Mayer who sold 3,000 units worth $76.8K . In the last 13 years, insiders at Oramed Pharmaceuticals Inc have sold an estimated value of $12.41M and bought an estimated value of $6.19M worth of shares. Insider trading is most common in February, with the busiest year in 2022. The most active traders at the company are Miriam Kidron, Chief Scientific Officer, Nadav Kidron, President and CEO, and Leonard Sank, Director .
ORAMED PHARMACEUTICALS INC. Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||